Bocquet Nicolas, Kohler Josiane, Hug Melanie N, Kusznir Eric A, Rufer Arne C, Dawson Roger J, Hennig Michael, Ruf Armin, Huber Walter, Huber Sylwia
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Biochim Biophys Acta. 2015 May;1848(5):1224-33. doi: 10.1016/j.bbamem.2015.02.014. Epub 2015 Feb 25.
Membrane proteins (MPs) are prevalent drug discovery targets involved in many cell processes. Despite their high potential as drug targets, the study of MPs has been hindered by limitations in expression, purification and stabilization in order to acquire thermodynamic and kinetic parameters of small molecules binding. These bottlenecks are grounded on the mandatory use of detergents to isolate and extract MPs from the cell plasma membrane and the coexistence of multiple conformations, which reflects biochemical versatility and intrinsic instability of MPs. In this work ,we set out to define a new strategy to enable surface plasmon resonance (SPR) measurements on a thermostabilized and truncated version of the human adenosine (A2A) G-protein-coupled receptor (GPCR) inserted in a lipid bilayer nanodisc in a label- and detergent-free manner by using a combination of affinity tags and GFP-based fluorescence techniques. We were able to detect and characterize small molecules binding kinetics on a GPCR fully embedded in a lipid environment. By providing a comparison between different binding assays in membranes, nanodiscs and detergent micelles, we show that nanodiscs can be used for small molecule binding studies by SPR to enhance the MP stability and to trigger a more native-like behaviour when compared to kinetics on A2A receptors isolated in detergent. This work provides thus a new methodology in drug discovery to characterize the binding kinetics of small molecule ligands for MPs targets in a lipid environment.
膜蛋白(MPs)是参与许多细胞过程的常见药物发现靶点。尽管它们作为药物靶点具有很高的潜力,但由于在表达、纯化和稳定方面存在局限性,MPs的研究受到了阻碍,以便获取小分子结合的热力学和动力学参数。这些瓶颈基于必须使用去污剂从细胞质膜中分离和提取MPs,以及多种构象的共存,这反映了MPs的生化多功能性和内在不稳定性。在这项工作中,我们着手定义一种新策略,通过结合亲和标签和基于绿色荧光蛋白(GFP)的荧光技术,以无标记和无去污剂的方式对插入脂质双层纳米盘的人腺苷(A2A)G蛋白偶联受体(GPCR)的热稳定和截短版本进行表面等离子体共振(SPR)测量。我们能够检测和表征完全嵌入脂质环境中的GPCR上的小分子结合动力学。通过比较膜、纳米盘和去污剂胶束中的不同结合测定,我们表明与在去污剂中分离的A2A受体的动力学相比,纳米盘可用于通过SPR进行小分子结合研究,以增强MP稳定性并触发更类似天然的行为。因此,这项工作为药物发现提供了一种新方法,用于表征脂质环境中MPs靶点的小分子配体的结合动力学。